THE CORRELATION OF MATRIX METALLOPROTEINASE-9 WITH STROKE AND PREVALENCE, RISK FACTORS, AND KNOWLEDGE OF STROKE AMONG PALESTINIANS
Objectives: The research study aims to estimate the prevalence of the stroke, to evaluate the stroke associated risk factors, and to determine the factors and symptoms associated with the knowledge of the stroke among the Palestinian population. Furthermore, to find the association between matrix metalloproteinase-9 (MMP-9) levels and the stroke, the concentration of MMP-9 in the serum of stroke patients was measured.
Methods: The research study includes a cross-sectional survey that was conducted. The serum MMP-9 levels were also measured in 11 stroke patients using an ELISA reader. Statistical analysis was performed by GraphPad Prism version 8. Sociodemographic characteristics of stroke patients associated with stroke among the Palestinian population were also obtained and analyzed.
Results: The higher incidence of the stroke was in the patient’s ages between 51 and 60 years old, with 30 patients (46%) of the total stroke patients. The majority of the stroke patients 40 (60.6%) were having enough income. Most of the stroke patients (29, 43.9%) were none educated. The majority of the stroke patients 48 (72.2%) had a family member/s who has been diagnosed with a stroke. Most of the stroke patients 60 (90.9%) have sudden numbness, weakness in the face, arms, and legs. All the samples analyzed showed a marked increase in MMP-9 concentration.
Conclusions: The prevalence of stroke and the high risk of stroke were high among adults aged ≥51 years in Palestine. Hypertension was the highest risk factor for stroke. The serum MMP-9 could be an important prognostic factor for the stroke.
2. Khoshnam SE, Winlow W, Farzaneh M, Farbood Y, Moghaddam HF. Pathogenic mechanisms following ischemic stroke. Neurol Sci 2017;38:1167-86.
3. Yang Q, Tong X, Schieb L, Vaughan A, Gillespie C, Wiltz JL, et al. Vital signs: Recent trends in stroke death rates-United States, 2000-2015. MMWR Morb Mortal Wkly Rep 2017;66:933-9.
4. Beal CC. Gender and stroke symptoms: A review of the current literature. J Neurosci Nurs 2010;42:80-7.
5. Mattson MP, Duan W, Pedersen WA, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001;6:69-81.
6. Stroebele N, Müller-Riemenschneider F, Nolte CH, Müller-Nordhorn J, Bockelbrink A, Willich SN, et al. Knowledge of risk factors, and warning signs of stroke: A systematic review from a gender perspective. Int J Stroke 2011;6:60-6.
7. Sweileh WM, Sawalha AF, Al-Aqad SM, Zyoud SH, Al-Jabi SW. The epidemiology of stroke in Northern Palestine: A 1-year, hospital-based study. J Stroke Cerebrovasc Dis 2008;17:406-11.
8. Sawalha A. Characterization of hospitalized ischemic stroke patients in Palestine. Libyan J Med 2009;4:37-40.
9. Shahwan AJ, Abed Y, Desormais I, Magne J, Preux PM, Aboyans V, et al. Epidemiology of coronary artery disease and stroke and associated risk factors in Gaza community-Palestine. PLoS One 2019;14:e0211131.
10. Jackson CA, Sudlow CL, Mishra GD. Education, sex, and risk of stroke: A prospective cohort study in New South Wales, Australia. BMJ Open 2018;8:e024070.
11. Habibi-Koolaee M, Shahmoradi L, Kalhori SR, Ghannadan H, Younesi E. Prevalence of stroke risk factors and their distribution based on stroke subtypes in Gorgan: A retrospective hospital-based study-2015-2016. Neurol Res Int 2018;2018:2709654.
12. Al-Jishi AA, Mohan PK. Profile of stroke in Bahrain. Neurosciences (Riyadh) 2000;5:30-4.
13. Khedr EM, Abo Elfetoh N, Al Attar G, Ahmed MA, Ali AM, Hamdy A, et al. Epidemiological study and risk factors of stroke in Assiut Governorate, Egypt: A community-based study. Neuroepidemiology 2013;40:288-94.
14. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol 2012;12:117.
15. Li Y, Zhang X, Sang H, Niu X, Liu T, Liu W, et al. Urban-rural differences in risk factors for ischemic stroke in Northern China. Medicine (Baltimore) 2019;98:e15782.
16. Grimaud O, Dufouil C, Alpérovitch A, Pico F, Ritchie K, Helmer C, et al. Incidence of ischaemic stroke according to income level among older people: The 3C study. Age Aging 2011;40:116-21.
17. Wang S, Shen B, Wu M, Chen C, Wang J. Effects of socioeconomic status on risk of ischemic stroke: A case-control study in the Guangzhou population. BMC Public Health 2019;19:648.
18. Tetzlaff J, Geyer S, Tetzlaff F, Epping J. Income inequalities in stroke incidence and mortality: Trends in stroke-free and stroke-affected life years based on German health insurance data. PLoS One 2020;15:e0227541.
19. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet 2010;376:112-23.
20. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2011;42:517-84.
21. Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res 2017;120:439-48.
22. Zheng J, Sun Z, Guo, X, Xie Y, Sun Y, Zheng L. Blood pressure predictors of stroke in rural Chinese dwellers with hypertension: A large-scale prospective cohort study. BMC Cardiovasc Disord 2019;19:206.
23. Bijker JB, Gelb AW. Review article: The role of hypotension in perioperative stroke. J Can Anesth 2013;60:159-67.
24. Booth J, Connelly L, Lawrence M, Chalmers C, Joice S, Becker S, et al.Evidence of perceived psychosocial stress as a risk factor for stroke in adults: A meta-analysis. BMC Neurol 2015;15:233.
25. Kotl?ga D, Go??b-Janowska M, Masztalewicz M, Cie?wie? S, Nowacki P. The emotional stress and risk of ischemic stroke. Neurol Neurochir Pol 2016;50:265-70.
26. Mirzaee O, Saneian M, Vani JR, Shahrivar K, Peyravi M, Shariat A, et al. The Psychophysiological responses of the chronic ischemic stroke patients to acute stress were changed. Braz Arch Biol Technol 2019;62:e19180494.
27. Musaiger AO. Overweight and obesity in eastern mediterranean region: Prevalence and possible causes. J Obes 2011;2011:407237.
28. Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res 2017;120:472-95.
29. Chung JW, Kim BJ, Han MK, Kang K, Park JM, Park SS, et al. Family history and risk of recurrent stroke. Stroke 2016;47:1990-6.
30. Kulshreshtha A, Vaccarino V, Goyal A, McClellan W, Nahab F, Howard VJ, et al. Family history of stroke and cardiovascular health in a national cohort. J Stroke Cerebrovasc Dis 2015;24:447-54.
31. Abdelnaseer M, Elfayomi N, Esmail E, Kamal M, Elsawy E. Matrix metalloproteinase-9 and recovery of acute ischemic stroke. J Stroke Cerebrovasc Dis 2017;26:733-40.
32. Zhong C, Yang J, Xu T, Xu T, Peng Y, Wang A, et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology 2017;89:805-12.
33. Abdelnaseer M, Elfayomi N, Hassan E, Kamal M, Hamdy A, Elsawy E. Serum matrix metalloproteinase-9 in acute ischemic stroke and its relation to stroke severity. Egypt J Neurol Psychiatry Neurosurg 2015;52:274-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.